Pancreatic Cancer
Tag
Mar 26, 2025

‘Ultrarapid’ genomic testing could shift paradigm for cancer treatment
Jul 03, 2024

Study identifies two critical genes in pancreatic tumours
Aug 15, 2022

Trusting the gut in cancer research: Q&A with Dr. Saman Maleki
Jul 11, 2022

Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer
Jun 16, 2022

OICR announces funding for three new window-of-opportunity clinical trials
Sep 24, 2020

Clinical study simplifies precision medicine for pancreatic cancer patients
Jul 24, 2020

OICR research leads to new pancreatic cancer clinical trial with aim to change the standard of care for patients
Jan 13, 2020

Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer
Aug 13, 2019

How do cancer patients help future cancer patients? This is Ron’s story
Jul 30, 2019

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing
Jun 26, 2019

Patterns in pancreatic cancer samples lead to better prognostic power
May 30, 2019

Predicting the course of pancreatic cancer
Jan 25, 2019

Study reveals mechanism driving spread of advanced pancreatic cancer
Mar 06, 2018

Canadian pancreatic cancer research team provides personalized medicine, new hope to patients
Jan 30, 2018

Early results from COMPASS trial demonstrate benefits of using genomic sequencing to guide treatment for pancreatic cancer
May 25, 2017

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer
May 25, 2017

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers
Oct 21, 2016

OICR-led study finds four unique genomic signatures in pancreas cancer, uncovers potential of immunotherapies
Oct 12, 2016

New findings challenge current view of how pancreas cancer develops
Jun 01, 2015

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.